Investors Watch List: Johnson & Johnson (NYSE:JNJ), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), NanoString Technologies, Inc. (NASDAQ:NSTG), OvaScience (NASDAQ:OVAS), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Technology Stocks News 3

Johnson & Johnson (NYSE:JNJ) was the first major company from the drug manufacturing industry to post impressive second-quarter earnings. The NYSE ARCA Pharmaceutical Index is up almost 20.1% in the last year. So far in 2014, the index increased10%. Johnson & Johnson (NYSE:JNJ) belongs to Healthcare sector. Its net profit margin is 21.20% and weekly performance is 2.13%. On last trading day company shares ended up $104.19. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 1.19%.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) had a roller coaster week. The Boston-based biotech on Monday announced it was discontinuing US sales of its hepatitis C drug Incivek. But shares rallied later in the week, posting the biggest gain in the S&P 500 on Thursday — in part because of a narrower-than expected loss. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares fell -2.53% in last trading session and ended the day at $88.99. VRTX Gross Margin is 93.80% and its return on assets is -20.50%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) quarterly performance is 25.02%.

NanoString Technologies (NASDAQ:NSTG) Director Charles P. Waite, Jr. sold 18,557 shares of the company’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $12.05, for a total value of $223,611.85. On 21 August, NanoString Technologies, Inc. (NASDAQ:NSTG) shares moved up 0.17% and was closed at $11.49. NSTG EPS growth in last 5 year was 33.60%. NanoString Technologies, Inc. (NASDAQ:NSTG) year to date (YTD) performance is -33.35%.

Ovascience Inc. (NASDAQ:OVAS) issued its quarterly earnings data on Thursday, 07 Aug 2014. The company reported ($0.42) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.45) by $0.03. On the ratings front, analysts at HC Wainwright reiterated a “buy” rating on shares of Ovascience in a research note on Monday, May 12th. OvaScience, Inc. (NASDAQ:OVAS) ended the last trading day at $11.24. Company weekly volatility is calculated as 4.02%and price to cash ratio as 3.05. OvaScience, Inc. (NASDAQ:OVAS) showed a weekly performance of -6.72%.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s Hacksell Uli sold 15,000 shares at $22.89 per share. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is focused primarily on the commercialization and development of small molecule drugs for the treatment of central nervous system illnesses. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares fell -2.95% in last trading session and ended the day on $22.02. ACAD return on assets is -22.10%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) quarterly performance is 12.52%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone